MedTrace Logo

Effects of Intranasal Oxytocin on Emotion Regulation

NCT03055546 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-10-29

No results posted yet for this study

Summary

The aim is to examine whether intranasal oxytocin will influence the individuals' emotion regulation ability and related neural mechanisms.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

intranasal administration of oxytocin

DRUG

Placebo

intranasal administration of placebo

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith Kendrick, Dr. · University of Electronic Science and Technology of China

  • Benjamin Becker · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-12-31
Completion
2019-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055546 on ClinicalTrials.gov